Literature DB >> 33458768

The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart.

Kevin Chan1, Sharon M Moe2, Rajiv Saran3, Peter Libby4.   

Abstract

Chronic kidney disease (CKD) patients require dialysis to manage the progressive complications of uraemia. Yet, many physicians and patients do not recognize that dialysis initiation, although often necessary, subjects patients to substantial risk for cardiovascular (CV) death. While most recognize CV mortality risk approximately doubles with CKD the new data presented here show that this risk spikes to >20 times higher than the US population average at the initiation of chronic renal replacement therapy, and this elevated CV risk continues through the first 4 months of dialysis. Moreover, this peak reflects how dialysis itself changes the pathophysiology of CV disease and transforms its presentation, progression, and prognosis. This article reviews how dialysis initiation modifies the interpretation of circulating biomarkers, alters the accuracy of CV imaging, and worsens prognosis. We advocate a multidisciplinary approach and outline the issues practitioners should consider to optimize CV care for this unique and vulnerable population during a perilous passage. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  End-stage renal disease; Haemodialysis initiation; Sudden death

Mesh:

Year:  2021        PMID: 33458768      PMCID: PMC8014523          DOI: 10.1093/eurheartj/ehaa1049

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  138 in total

1.  B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison.

Authors:  Christian Mueller; Kirsten Laule-Kilian; André Scholer; Charly Nusbaumer; Thomas Zeller; Daniel Staub; André P Perruchoud
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

2.  Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions.

Authors:  Theodore F Saad; Waqas Ahmed; Karen Davis; Claudine Jurkovitz
Journal:  Semin Dial       Date:  2014-05-27       Impact factor: 3.455

3.  Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.

Authors:  John W McEvoy; Yuan Chen; Andreea Rawlings; Ron C Hoogeveen; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

Review 4.  The microinflammatory state in uremia: causes and potential consequences.

Authors:  George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients.

Authors:  K Iseki; F Miyasato; K Tokuyama; K Nishime; H Uehara; Y Shiohira; H Sunagawa; K Yoshihara; S Yoshi; S Toma; T Kowatari; T Wake; T Oura; K Fukiyama
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

6.  Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.

Authors:  Bruce F Culleton; Michael Walsh; Scott W Klarenbach; Garth Mortis; Narine Scott-Douglas; Robert R Quinn; Marcello Tonelli; Sarah Donnelly; Matthias G Friedrich; Andreas Kumar; Houman Mahallati; Brenda R Hemmelgarn; Braden J Manns
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

7.  Hemodialysis-induced cardiac injury: determinants and associated outcomes.

Authors:  James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

8.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Mintu P Turakhia; Peter J Blankestijn; Juan-Jesus Carrero; Catherine M Clase; Rajat Deo; Charles A Herzog; Scott E Kasner; Rod S Passman; Roberto Pecoits-Filho; Holger Reinecke; Gautam R Shroff; Wojciech Zareba; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christoph Wanner
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983

10.  Impact of Chronic Kidney Disease on Short-Term Cardiac Implantable Electronic Device Related Infection: A Nationwide Population-Based Cohort Study.

Authors:  Yu-Sheng Lin; Tien-Hsing Chen; Ming-Shyan Lin; Dong Yi Chen; Chun-Tai Mao; Jen-Te Hsu; Huang-Chung Chen; Mien-Cheng Chen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  2 in total

Review 1.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

2.  The Effect of Humanistic Care Combined with Predictive Nursing on Negative Emotions and Incidence of Cardiovascular Events in Hemodialysis Patients.

Authors:  Yanling Wang; Changmin Su
Journal:  Comput Math Methods Med       Date:  2022-04-29       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.